225 related articles for article (PubMed ID: 20035012)
1. Definitive hematopoiesis requires Runx1 C-terminal-mediated subnuclear targeting and transactivation.
Dowdy CR; Xie R; Frederick D; Hussain S; Zaidi SK; Vradii D; Javed A; Li X; Jones SN; Lian JB; van Wijnen AJ; Stein JL; Stein GS
Hum Mol Genet; 2010 Mar; 19(6):1048-57. PubMed ID: 20035012
[TBL] [Abstract][Full Text] [Related]
2. A germline point mutation in Runx1 uncouples its role in definitive hematopoiesis from differentiation.
Dowdy CR; Frederick D; Zaidi SK; Colby JL; Lian JB; van Wijnen AJ; Gerstein RM; Stein JL; Stein GS
Exp Hematol; 2013 Nov; 41(11):980-991.e1. PubMed ID: 23823022
[TBL] [Abstract][Full Text] [Related]
3. Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1.
Li X; Vradii D; Gutierrez S; Lian JB; van Wijnen AJ; Stein JL; Stein GS; Javed A
J Cell Biochem; 2005 Nov; 96(4):795-809. PubMed ID: 16149049
[TBL] [Abstract][Full Text] [Related]
4. Nonredundant roles for Runx1 alternative promoters reflect their activity at discrete stages of developmental hematopoiesis.
Bee T; Swiers G; Muroi S; Pozner A; Nottingham W; Santos AC; Li PS; Taniuchi I; de Bruijn MF
Blood; 2010 Apr; 115(15):3042-50. PubMed ID: 20139099
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation of Runx1 regulatory regions correlates with transition from primitive to definitive hematopoietic potential in vitro and in vivo.
Webber BR; Iacovino M; Choi SH; Tolar J; Kyba M; Blazar BR
Blood; 2013 Oct; 122(17):2978-86. PubMed ID: 24030384
[TBL] [Abstract][Full Text] [Related]
6. Identification of an N-terminal transactivation domain of Runx1 that separates molecular function from global differentiation function.
Liu H; Carlsson L; Grundström T
J Biol Chem; 2006 Sep; 281(35):25659-69. PubMed ID: 16803898
[TBL] [Abstract][Full Text] [Related]
7. Genetic evidence of PEBP2beta-independent activation of Runx1 in the murine embryo.
Yokomizo T; Yanagida M; Huang G; Osato M; Honda C; Ema M; Takahashi S; Yamamoto M; Ito Y
Int J Hematol; 2008 Sep; 88(2):134-138. PubMed ID: 18594778
[TBL] [Abstract][Full Text] [Related]
8. The differential activities of Runx1 promoters define milestones during embryonic hematopoiesis.
Sroczynska P; Lancrin C; Kouskoff V; Lacaud G
Blood; 2009 Dec; 114(26):5279-89. PubMed ID: 19858498
[TBL] [Abstract][Full Text] [Related]
9. Loss of RUNX1/AML1 arginine-methylation impairs peripheral T cell homeostasis.
Mizutani S; Yoshida T; Zhao X; Nimer SD; Taniwaki M; Okuda T
Br J Haematol; 2015 Sep; 170(6):859-73. PubMed ID: 26010396
[TBL] [Abstract][Full Text] [Related]
10. A role for RUNX1 in hematopoiesis and myeloid leukemia.
Ichikawa M; Yoshimi A; Nakagawa M; Nishimoto N; Watanabe-Okochi N; Kurokawa M
Int J Hematol; 2013 Jun; 97(6):726-34. PubMed ID: 23613270
[TBL] [Abstract][Full Text] [Related]
11. Developmentally regulated promoter-switch transcriptionally controls Runx1 function during embryonic hematopoiesis.
Pozner A; Lotem J; Xiao C; Goldenberg D; Brenner O; Negreanu V; Levanon D; Groner Y
BMC Dev Biol; 2007 Jul; 7():84. PubMed ID: 17626615
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of the RUNX1-target gene NR4A3 contributes to hematopoiesis deregulation in familial platelet disorder/acute myelogenous leukemia.
Bluteau D; Gilles L; Hilpert M; Antony-Debré I; James C; Debili N; Camara-Clayette V; Wagner-Ballon O; Cordette-Lagarde V; Robert T; Ripoche H; Gonin P; Swierczek S; Prchal J; Vainchenker W; Favier R; Raslova H
Blood; 2011 Dec; 118(24):6310-20. PubMed ID: 21725049
[TBL] [Abstract][Full Text] [Related]
13. A Runx1-Smad6 rheostat controls Runx1 activity during embryonic hematopoiesis.
Knezevic K; Bee T; Wilson NK; Janes ME; Kinston S; Polderdijk S; Kolb-Kokocinski A; Ottersbach K; Pencovich N; Groner Y; de Bruijn M; Göttgens B; Pimanda JE
Mol Cell Biol; 2011 Jul; 31(14):2817-26. PubMed ID: 21576367
[TBL] [Abstract][Full Text] [Related]
14. Distinct mechanisms of regulation of the ITGA6 and ITGB4 genes by RUNX1 in myeloid cells.
Phillips JL; Taberlay PC; Woodworth AM; Hardy K; Brettingham-Moore KH; Dickinson JL; Holloway AF
J Cell Physiol; 2018 Apr; 233(4):3439-3453. PubMed ID: 28926098
[TBL] [Abstract][Full Text] [Related]
15. RUNX1 inhibits proliferation and induces apoptosis of t(8;21) leukemia cells
Liu S; Xing Y; Lu W; Li S; Tian Z; Xing H; Tang K; Xu Y; Rao Q; Wang M; Wang J
Haematologica; 2019 Aug; 104(8):1597-1607. PubMed ID: 30792202
[TBL] [Abstract][Full Text] [Related]
16. Core-binding factor beta (CBFbeta), but not CBFbeta-smooth muscle myosin heavy chain, rescues definitive hematopoiesis in CBFbeta-deficient embryonic stem cells.
Miller JD; Stacy T; Liu PP; Speck NA
Blood; 2001 Apr; 97(8):2248-56. PubMed ID: 11290585
[TBL] [Abstract][Full Text] [Related]
17. Runx transcription factors in the development and function of the definitive hematopoietic system.
de Bruijn M; Dzierzak E
Blood; 2017 Apr; 129(15):2061-2069. PubMed ID: 28179276
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic stem cell emergence in the conceptus and the role of Runx1.
Swiers G; de Bruijn M; Speck NA
Int J Dev Biol; 2010; 54(6-7):1151-63. PubMed ID: 20711992
[TBL] [Abstract][Full Text] [Related]
19. Development of multilineage adult hematopoiesis in the zebrafish with a runx1 truncation mutation.
Sood R; English MA; Belele CL; Jin H; Bishop K; Haskins R; McKinney MC; Chahal J; Weinstein BM; Wen Z; Liu PP
Blood; 2010 Apr; 115(14):2806-9. PubMed ID: 20154212
[TBL] [Abstract][Full Text] [Related]
20. Runx1/AML1 in normal and abnormal hematopoiesis.
Yamagata T; Maki K; Mitani K
Int J Hematol; 2005 Jul; 82(1):1-8. PubMed ID: 16105753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
